Free fatty acid receptors, FFAR1 and FFAR4, are novel bronchodilator targets in mouse and human precision-cut lung slices
J. Bourke (Melbourne, Australia), R. Angeles (Melbourne, Australia), C. Donovan (Melbourne, Australia), M. Lam (Melbourne, Australia), J. Micallef (Melbourne, Australia), B. Shimpukade (Odense, Denmark), T. Ulven (Copenhagen, Denmark), S. Royce (Melbourne, Australia)
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Bourke (Melbourne, Australia), R. Angeles (Melbourne, Australia), C. Donovan (Melbourne, Australia), M. Lam (Melbourne, Australia), J. Micallef (Melbourne, Australia), B. Shimpukade (Odense, Denmark), T. Ulven (Copenhagen, Denmark), S. Royce (Melbourne, Australia). Free fatty acid receptors, FFAR1 and FFAR4, are novel bronchodilator targets in mouse and human precision-cut lung slices. 5259
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: